Evryal Strong
[IT]
Treatment of medium to deep face wrinkles, volume augmentation of cheekbones, chin, nose bridge, and to redefine the mandibular profile. The linear retrograde technique should be preferred over the sequential micro-bump technique. It is recommended to inject the product at the deep dermis level.
Indications:
- CHEEKBONES
- NOSE
- NASOGENIC WRINKLES
- CHIN
- MANDIBULAR PROFILE
| CONCENTRATION | 25 mg/ml |
| PH | 6.00 – 7.50 |
| INITIAL HYALURONIC ACID MOLECULAR WEIGHT | 2,400-4,000 kDa |
| TOTAL ENDOTOXINS | < 0.5 EU/ml |
| INDICATIONS FOR USE | Treatment of deep facial wrinkles |
| INJECTION AREA | Deep hypodermis or supraperiosteal |
| CROSS-LINKING AGENT | BDDE |
| FREE BDDE | < 50ppb |
| QUANTITY PER BOX | Sterile syringe 1×1 mL |
| DURATION OF RESULTS | 6-8 Months |
| NEEDLES | 1x27G 1/2” – 1x26G 1/2” |
| STERILIZATION | Autoclave |
MEDICAL DEVICE CE 0373
* The Application of the Product is Reserved Exclusively for Professional Healthcare Operators with Suitable Qualifications.
[EN]
Treatment of medium to deep face wrinkles, volume augmentation of cheekbones, chin, nose bridge, and lips. The linear retrograde technique should be chosen over the serial puncture technique. We recommend injecting the product into the deep dermal layer.
MEDICAL DEVICE CE 0373
- NOSE
- NASOGENIC WRINKLES
- CHIN
- MANDIBULAR PROFILE
| CONCENTRATION | 25 mg/ml |
| PH | 6.00 – 7.50 |
| INITIAL HYALURONIC ACID MOLECULAR WEIGHT | 2,400-4,000 kDa |
| TOTAL ENDOTOXINS | < 0.5 EU/ml |
| INDICATIONS | Treatment of deep facial wrinkles |
| INJECTION AREA | Deep or supraperiosteal hypodermis |
| CROSS-LINKING AGENT | BDDE |
| FREE BDDE | < 50ppb |
| ONE BOX CONTAINS | Sterile syringe 1×1 mL |
| DURATION OF RESULTS | 6-8 Months |
| NEEDLES | 1x27G 1/2” – 1x26G 1/2” |
| STERILIZATION | Autoclave |
